EUVIMEDEUVIMED entdecken
Crossref

Early-onset Parkinson’s disease: clinical findings and progression

Didem Tezen, Furkan Sefa Bayır, Cihan İşler, Hülya Apaydın, Ayşegül Gündüz

Neurological Sciences · 2026-04 · 47 (4)

DOI: 10.1007/s10072-026-08982-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurological Sciences, online erschienen am 25.03.2026. Verfasst von Didem Tezen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Istanbul, Turkey. didemtezen@gmail.com. Hauptthemen laut MEDLINE: Parkinson Disease, Disease Progression. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This study investigated the prevalence, clinical features, and treatment characteristics of early-onset Parkinson's disease (EOPD) in a tertiary centre in Turkey. METHODS: Medical records of 1,878 patients diagnosed with EOPD and idiopathic Parkinson's disease (iPD) between January 2010 and August 2024 were retrospectively reviewed. Patients diagnosed with EOPD and iPD were identified. The EOPD group and the iPD group were defined as patients with an age of onset ≤ 50 years and between 50 and 70 years, respectively. RESULTS: There were 388 patients in the EOPD group and 997 patients in the iPD group. The mean disease duration was significantly longer, and the Mean Hoehn-Yahr Scale (HYS) scores and the mean levodopa-equivalent dose (LEDD) were similar. In the EOPD group, there was a slight correlation between disease duration and HYS score (p < 0.000, r = 0.282). Temporal trend analyses demonstrated distinct longitudinal patterns between EOPD and iPD. In the interaction model for LDED, both groups showed a decline in LDED over time; the rate of reduction was steeper in the iPD group. For the HYS, no significant temporal change was detected, and the interaction term was non-significant, suggesting similar progression trajectories between EOPD and iPD (Table 2). CONCLUSION: EOPD cases in our cohort have a longer disease course. Although they have a longer disease duration, the mean LEDD and motor complications are similar to those in typical PD cases. Overall, these findings highlight the clinical heterogeneity of EOPD and emphasize the importance of tailored long-term management strategies in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseDisease ProgressionHumansFemaleMaleMiddle AgedRetrospective StudiesAge of OnsetAgedTurkeyAntiparkinson AgentsLevodopaSeverity of Illness Index

Stichwörter der Autor:innen

EOPDEarly-onset Parkinson's diseaseLevodopa-equivalent dose

Substanzen

Antiparkinson AgentsLevodopa

Autor:innen und Institutionen

  • Department of Neurology, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Istanbul, Turkey. didemtezen@gmail.com.
  • Department of Neurology, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Istanbul, Turkey.
  • Cerrahpasa School of Medicine, Department of Neurosurgery, Istanbul University-Cerrahpasa, Istanbul, Turkey.

Zitieren

APA

Tezen, D., Bayır, F. S., İşler, C., Apaydın, H., & Gündüz, A. (2026). Early-onset Parkinson’s disease: clinical findings and progression. Neurological Sciences, 47(4). https://doi.org/10.1007/s10072-026-08982-w

Vancouver

Tezen D, Bayır FS, İşler C, Apaydın H, Gündüz A. Early-onset Parkinson’s disease: clinical findings and progression. Neurological Sciences. 2026;47(4). doi:10.1007/s10072-026-08982-w

BibTeX
@article{Tezen2026,
  author = {Tezen, Didem and Bayır, Furkan Sefa and İşler, Cihan and Apaydın, Hülya and Gündüz, Ayşegül},
  title = {Early-onset Parkinson’s disease: clinical findings and progression},
  journal = {Neurological Sciences},
  year = {2026},
  volume = {47},
  number = {4},
  doi = {10.1007/s10072-026-08982-w}
}
Kostenlos starten →